Marc Friedli

@epfl @health2030swiss

[Maillard Lab @MaillardLab]

Interested in #innateimmunity and #Virology? We have two positions: a #postdoc and a research assistant in my lab @blizard_inst @QMUL !

More details here:

Postdoc: https://t.co/jVsqWpATfx

Research Assistant: https://t.co/0dK5STvV0p

Please RT and/or apply!

[Tulio de Oliveira @Tuliodna]

We proudly announce that we have united with top European and African institutions to create a Cluster of Excellence in Genomics for Health in Africa - A press release of our CoE is out today! - 1/3 https://t.co/A5NDt3sbtr @StellenboschUni @UKZNCHS @MCIDBern @shahida_moosa

[Geneva Centre for Emerging Viral Diseases @gcevd]

There'll still be a few mini updates but otherwise program is final (1-2 more speakers still pending!)! Check out: Lots of exciting sessions, talks & speakers! Topics: #SARSCoV2 #monkeypox #arboviruses #climatechange #ebola #poxviruses #vaccines & more! https://t.co/cs0twKAd1D

[David Suter @davidsuter_epfl]

🥳🤓 Job alert: my lab has a PhD student + a post-doc position opening
👉 study the role of histone variants & chromatin remodelers in cell identity regulation through cell division
🛠️ genomics, genome editing, live cell single molecule imaging
Contact me if interested !
🙏 RT

[Dr Emma Hodcroft @firefoxx66]

What should we expect from #SARSCoV2 this autumn?

I think it would be smart to prepare for both an increase in #COVID19 due to seasonal (behavioural) change & a new variant.
As so many others have elegantly illustrated, new lineages of SC2 are sparking interest.

1/17

[Dr Emma Hodcroft @firefoxx66]

For emphasis:
Sequencing is here. It is going to be one of our most crucial tools for public health in the future.

Countries have a chance now to invest & be at the forefront of this advance for better preparedness & protection.
What would you like your country to do?

[idris guessous @iguessous]

If concerned by #PostCovid please contact [email protected] for more information on the clinical trial we are about to start in Geneva @Hopitaux_unige @UNIGEnews

[Nexco Analytics @nexcoanalytics]

Glad to be an EPFL startup!

[idris guessous @iguessous]

Nous n’avons pas encore toutes les réponses, mais nous écoutons déjà toutes vos questions sur le #postcovid Immense gratitude a notre équipe #RAFAEL pour cet immense travail powered by @mayssamnehme @Hopitaux_unige @UNIGEnews

[Geneva Centre for Emerging Viral Diseases @gcevd]

Interested in #SARSCoV2 #COVID19 & #variants in #Geneva? Here's the website with our regular reports from the Centre for Emerging Viral Diseases & Swiss national SARS-CoV-2 genomic & #variants surveillance program @BAG_OFSP_UFSP @Hopitaux_unige @unige_en https://t.co/zORI6Xud1g

[Dessins de Chappatte @chappatte]

Covid, bientôt le bout? - En une du journal Le Monde daté de ce mercredi 👇

[Caroline Samer @caroline_samer]

Very honored to have co-edited this research topic on “Precision Medicine: impact of CYP450 and transporters genetic polymorphisms, DDI, disease on safety and efficacy of drugs” . #pharmacogenomics #precisionmedicine @FrontPharmacol
See our editorial: https://t.co/mWPtNRnJC2

[Dr Emma Hodcroft @firefoxx66]

While boosters should not be the only course of action, they are 1 thing we can do to help against Omicron easily & quickly in countries where available.

Why are we sticking to "6 months" in #Switzerland when we could go much faster?? #boostSwitzerland

https://t.co/q04eNRVppM

[franck schneider @fksc_]

Le Centre national de référence pour les infections virales émergentes @Hopitaux_unige se mobilise pour une détection rapide du variant #Omicron #CoronaInfoCH #COVID19 https://t.co/LwdvBpu19Z

[Mathias Reynard @MathiasReynard]

État des lieux de la vaccination en Valais:
75% des + de 16 ans ont déjà reçu au moins une dose 💉

Le détail par classes d’âge
↗️ 16-19 ans : 60%
↗️ 20-29 ans : 61%
↗️ 30-39 ans : 64%
↗️ 40-49 ans : 71%
↗️ 50-59 ans : 77%
↗️ 60-69 ans : 84%
↗️ 70-79 ans : 93%
↗️ +80 ans : 96%

[Heidi.news @heidi_news]

Laurent Kaiser a — bien avant l’avènement des pandémies du H1N1 en 2019 et du Covid-19 — concentré ses recherches sur les virus respiratoires, à l’instar des rhinovirus, du coronavirus et de la grippe https://t.co/groCejSMY0